Vital Therapies (NASDAQ:VTL)
Cell-based therapy targeting the treatment of acute liver failure.
Get a Demo and See the Full Profile
Get a demo today to see profiles of Vital Therapies (NASDAQ:VTL) plus 5903 other startups.
Cell-based therapy targeting the treatment of acute liver failure.
Get a demo today to see profiles of Vital Therapies (NASDAQ:VTL) plus 5903 other startups.
© 2024 Life Science Intelligence, Inc., All Rights Reserved.
